LIANBIO |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.305 USD | -2.89% |
|
+8.62% | -93.18% |
| Mar. 18 | LianBio(OTCPK:LIAN.Y) dropped from NASDAQ Composite Index | CI |
| Mar. 15 | ADRs End Lower; Akso Health Group Declines 23% | DJ |
Chart calendar LianBio
08c49a625960023f.zxepqrMhIWbgP-iWLvIDKlPUax7ZyRGE7dcpR345xt8.oG6d8-x5Fw-Rb4mkZJVKUjHlNEewpkPBrJxCMgldrpb-fP2HglV0UKZv2A~827da84797e005ce10c5087e190f3643
Upcoming events on LianBio
Past events on LianBio
| 2023-11-13 04:05 pm | Q3 2023 Earnings Release |
| 2023-08-28 11:00 am | European Society of Cardiology Congress |
| 2023-08-14 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-21 08:00 am | Annual General Meeting |
| 2023-06-15 01:00 pm | Goldman Sachs Global Healthcare Conference - Fireside Chat |
| 2023-06-08 04:30 pm | Jefferies Global Healthcare Conference - Fireside Chat |
| 2023-05-11 04:15 pm | Q1 2023 Earnings Release |
| 2023-05-01 08:00 am | Business Update Call |
| 2023-03-27 08:36 am | Q4 2022 Earnings Release |
| 2022-11-16 04:15 pm | BioCentury-BayHelix East-West Biopharma Summit - Panel |
| 2022-11-16 05:55 am | Jefferies London Healthcare Conference |
| 2022-11-15 05:48 pm | BioCentury-BayHelix East-West Biopharma Summit |
| 2022-11-15 12:00 pm | BioCentury-BayHelix East-West Biopharma Summit - Panel |
| 2022-11-14 08:00 pm | Goldman Sachs Asia Pacific Healthcare Forum - Panel |
| 2022-11-10 04:05 pm | Q3 2022 Earnings Release |
| 2022-08-11 04:05 pm | Interim 2022 Earnings Release |
| 2022-06-15 05:40 pm | Goldman Sachs Global Healthcare Conference |
| 2022-06-10 11:00 am | Jefferies Healthcare Conference |
| 2022-05-12 09:20 am | Bank of America Healthcare Conference |
| 2022-05-12 08:00 am | Q1 2022 Earnings Release |
Past dividends on LianBio
| 2024-03-14 | 4.75 USD |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 6,67 - |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -195 -209 6.83% | -124 -123 -1.26% |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -196 -206 5.09% | -125 -126 0.31% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -196 -198 1.16% | -111 -114 2.56% |
|
Net income Million USD | Released Forecast Spread | -140 | -196 -204 3.94% | -110 -118 6.3% |
|
EPS USD | Released Forecast Spread | -67,7 | -5,71 -4,51 -26.7% | -1,02 -1,23 17.3% |
| Announcement Date | 09/08/21 | 30/03/22 | 27/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 6,67 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -13,3 -39,1 66.02% | -21,8 -35,8 39.05% | -28,1 -23,0 -22.37% | -43,0 -29,0 -48.29% | -23,5 -44,3 47.06% | -28,9 -5,01 -477.41% | -25,6 -31,7 18.97% | -24,7 -32,0 22.77% | -26,0 -36,1 27.98% |
|
EBIT Million USD | Released Forecast Spread | -13,5 -22,2 39.1% | -22,0 -32,6 32.46% | -60,5 -24,4 -148.4% | -43,1 -29,1 -48.06% | -24,5 -42,4 42.14% | -29,2 -29,6 1.34% | -26,0 -29,9 13.28% | -25,0 -32,1 22.03% | -26,3 -36,4 27.71% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,5 -20,0 32.47% | -22,2 -24,6 9.52% | -60,6 -23,6 -156.47% | -42,4 -30,3 -39.96% | -21,9 -44,4 50.72% | -18,6 -20,3 8.45% | -23,6 -32,0 26.25% | -21,4 -25,6 16.28% | -23,5 -24,3 3.49% |
|
Net income Million USD | Released Forecast Spread | -13,1 -30,7 57.29% | -21,2 -30,3 29.95% | -61,6 -22,0 -179.99% | -42,4 -30,6 -38.66% | -21,9 -45,0 51.33% | -18,3 -22,9 20.24% | -24,0 -29,0 17.11% | -21,6 -28,9 25.27% | -24,0 -29,5 18.6% |
|
EPS USD | Released Forecast Spread | -0,63 -0,35 -81.73% | -0,28 -0,33 15.15% | -3,01 -0,26 -1057.69% | -0,39 -0,28 -37.65% | -0,20 -0,42 52% | -0,17 -0,22 21.54% | -0,22 -0,27 19.51% | -0,20 -0,27 25.93% | -0,22 -0,29 22.81% |
| Announcement Date | 09/12/21 | 30/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 27/03/23 | 11/05/23 | 14/08/23 | 13/11/23 |
More events
Past sector events for LianBio
| 2024-05-03 07:00 am | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:02 pm | ARDELYX, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-02 04:00 pm | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 2024-05-02 11:00 am | GENMAB A/S: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | GERON CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LIANY Stock
- Calendar LianBio
